These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7014043)

  • 1. Combined captopril and spironolactone treatment in Conn's syndrome with renal impairment and refractory hypertension.
    Atkinson AB; Brown JJ; Davies DL; Lever AF; Robertson JI
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):105-8. PubMed ID: 7014043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body elemental composition, with particular reference to total and exchangeable sodium and potassium and total chlorine, in untreated and treated primary hyperaldosteronism.
    Williams ED; Boddy K; Brown JJ; Cumming AM; Davies DL; Harvey IR; Haywood JK; Lever AF; Robertson JI
    J Hypertens; 1984 Apr; 2(2):171-6. PubMed ID: 6533185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in a patient with hypercalcemia: captopril and verapamil.
    Waeber B; Brunner HR; Burckhardt P; Gavras H
    Arch Intern Med; 1982 Jan; 142(1):143-5. PubMed ID: 7032443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
    Atkinson AB; Brown JJ; Davies DL; Leckie B; Lever AF; Morton JJ; Robertson JI
    Hypertension; 1981; 3(1):53-8. PubMed ID: 7009427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril before and after spironolactone therapy in primary aldosteronism. Pathogenetic and therapeutical aspects.
    Stimpel M; Vetter W; Groth H; Greminger P; Vetter H
    Klin Wochenschr; 1985 Apr; 63(8):361-3. PubMed ID: 3889485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism.
    Luderer JR; Demers LM; Harrison TS; Hayes AH
    Clin Pharmacol Ther; 1982 Mar; 31(3):305-11. PubMed ID: 6277545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conn's syndrome. Study of systemic cardiovascular hemodynamics after medical treatment with spironolactone and after surgical treatment].
    Amah G; Blacher J; Girerd X; Kheder A; Ben Maiz H; Safar M
    Presse Med; 1997 Oct; 26(29):1372-7. PubMed ID: 9404344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of blood pressure with body and plasma electrolytes in Conn's syndrome.
    Beretta-Piccoli C; Davies DL; Brown JJ; Ferriss B; Fraser R; Lasaridis A; Lever AF; Morton JJ; Robertson JI; Semple PF
    J Hypertens; 1983 Aug; 1(2):197-205. PubMed ID: 6681039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome (author's transl)].
    Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
    Dtsch Med Wochenschr; 1980 May; 105(18):647-51. PubMed ID: 7371530
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H; Vetter W
    Klin Wochenschr; 1975 Apr; 53(8):391-3. PubMed ID: 211313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.
    Johnston CI; Millar JA; McGrath BP; Matthews PG
    Lancet; 1979 Sep; 2(8141):493-6. PubMed ID: 90216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism.
    Fraser R; Beretta-Piccoli C; Brown JJ; Cumming AM; Lever AF; Mason PA; Morton JJ; Robertson JI
    Hypertension; 1981; 3(3 Pt 2):I87-92. PubMed ID: 7262982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors: past, present, and bright future.
    Edwards CR; Padfield PL
    Lancet; 1985 Jan; 1(8419):30-4. PubMed ID: 2856956
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics.
    Brouwer RM; Bolli P; Erné P; Conen D; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S88-91. PubMed ID: 2580183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentration of renin in a patient with Conn's syndrome with fibrinoid lesions of the renal arterioles: the effect of treatment with spironolactone.
    Brown JJ; Davies DL; Lever AF; Peart WS; Robertson JI
    J Endocrinol; 1965 Oct; 33(2):279-93. PubMed ID: 5845288
    [No Abstract]   [Full Text] [Related]  

  • 17. Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
    Mooser V; Waeber G; Bidiville J; Waeber B; Nussberger J; Brunner HR
    J Clin Hypertens; 1987 Dec; 3(4):510-3. PubMed ID: 2839627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern pharmacological aspects of hyperaldosteronism therapy].
    Quinkler M; Reincke M
    Internist (Berl); 2006 Sep; 47(9):953-9. PubMed ID: 16823578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
    MacGregor GA; Markandu ND; Banks RA; Bayliss J; Roulston JE; Jones JC
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):693-6. PubMed ID: 6802291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril in the treatment of clinical hypertension and cardiac failure.
    Atkinson AB; Robertson JI
    Lancet; 1979 Oct; 2(8147):836-9. PubMed ID: 90928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.